An analysis of pre-treatment tumor specimens from 105 patients with localized muscle-invasive bladder cancer found that the presence of a mutation in any one of three genes, all known to be involved in DNA damage repair, ...
Jul 29, 2024
0
0
A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at the U, and Boston University Chobanian & Avedisian School of Medicine has found ...
Jul 17, 2024
0
9
Splenic venous hypertension (SVH), also known as left-sided portal hypertension, is a rare condition characterized by upper gastrointestinal (GI) bleeding in the absence of liver disease. This condition arises due to increased ...
Jul 16, 2024
0
0
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumor infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) ...
Jul 10, 2024
0
8
Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a five-year study led by Houston Methodist ...
Jun 12, 2024
0
0
Scientists at the University of Southern California have developed an artificial intelligence (AI)-powered system to track tiny devices that monitor markers of disease in the gut. Devices using the novel system may help at-risk ...
Jun 12, 2024
0
44
A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene ...
May 15, 2024
0
0
Breast-conserving surgery (BCS), also called lumpectomy, involves the removal of a cancerous lump and some surrounding tissue. BCS is suitable for women with early-stage breast cancer or small lumps, as it preserves more ...
May 9, 2024
0
39
Global immunization efforts have saved at least 154 million lives in the past 50 years, the World Health Organization said Wednesday, adding that most of those to benefit were infants.
Apr 24, 2024
0
10
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
Apr 23, 2024
0
1
